首页 > 最新文献

Journal Francais D Ophtalmologie最新文献

英文 中文
Visual outcomes after implantation of a presbyopia-correcting IOL that combines extended depth-of-focus and progressive phase complementarity optics 结合扩展聚焦深度和渐进相位互补光学的老花眼矫正人工晶体植入术后的视力结果
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-27 DOI: 10.1016/j.jfo.2025.104770
J. Le Dinahet, A.-A. Benyoussef, B. Cochener-Lamard
<div><h3>Purpose</h3><div>To evaluate clinical outcomes after implantation of new presbyopia-correcting intraocular lens (IOL): Artis Symbiose® (Cristalens Industrie, France).</div></div><div><h3>Setting</h3><div>Tertiary referral center, Brest, France.</div></div><div><h3>Design</h3><div>Non-comparative prospective interventional study.</div></div><div><h3>Methods</h3><div>Patients undergoing bilateral IOL implantation were included. Visual acuity (VA) for distance, intermediate (70<!--> <!-->cm) and near (40<!--> <!-->cm) vision were measured. In addition, defocus curves were obtained at 1 and 6<!--> <!-->months, and a reading speed test was assessed using the Salzburg Reading Desk® (SRD) 3<!--> <!-->months after surgery. The VF-14 questionnaire was evaluated at 1, 3 and 6<!--> <!-->months after surgery to measure spectacle independence, and a level of satisfaction questionnaire was completed at the 6-month follow-up visit.</div></div><div><h3>Results</h3><div>The study included 48 eyes. Mean postoperative monocular uncorrected VA, for MID and PLUS respectively, was 0.028<!--> <!-->±<!--> <!-->0.08 LogMAR and 0.057<!--> <!-->±<!--> <!-->0.10 at distance (UDVA), 0.035<!--> <!-->±<!--> <!-->0.10 and 0.037<!--> <!-->±<!--> <!-->0.09 at intermediate (UIVA), 0.078<!--> <!-->±<!--> <!-->0.11 and 0.030<!--> <!-->±<!--> <!-->0.10 at near (UNVA). Binocularly, uncorrected VA was −0.022<!--> <!-->±<!--> <!-->0.02 at distance, −0.002 at intermediate, and 0.015 at near. The binocular defocus curve at 6<!--> <!-->months after surgery was above 0 LogMAR between +0.50 D and −2.50 D. The mean satisfaction rate at 6<!--> <!-->months was 83%.</div></div><div><h3>Conclusion</h3><div>The Artis Symbiose® IOL provides functional uncorrected visual acuity at distance, intermediate and near positions, without the need for additional optical aid. It is an effective option in active presbyopic patients, with a continuous and extended depth-of-focus, providing added value compared to trifocal implants.</div></div><div><h3>Objectif</h3><div>Évaluer les résultats cliniques après implantation d’une nouvelle lentille intraoculaire (LIO) correctrice de la presbytie : modèle Artis Symbiose® (Cristalens Industrie, France).</div></div><div><h3>Lieu</h3><div>Centre de référence tertiaire, Brest, France.</div></div><div><h3>Design</h3><div>Étude prospective interventionnelle non comparative.</div></div><div><h3>Méthodes</h3><div>Les patients bénéficiant d’une implantation bilatérale de LIO ont été inclus. L’acuité visuelle (AV) en vision de loin, intermédiaire (70<!--> <!-->cm) et de près (40<!--> <!-->cm) a été mesurée. De plus, les courbes de défocalisation ont été obtenues à 1 et 6 mois, et un test de vitesse de lecture a été évalué à l’aide du Salzburg Reading Desk® (SRD) 3 mois après l’intervention. Le questionnaire VF-14 a été évalué à 1, 3 et 6 mois après l’intervention pour mesurer l’indépendance vis-à-vis des lunettes et un questionnaire de satisfaction a été rempli lors d
目的评价Artis Symbiose®(Cristalens Industrie,法国)新型老花眼矫正人工晶状体植入术的临床效果。三级转诊中心,布雷斯特,法国。设计:非比较性前瞻性介入研究。方法选取双侧人工晶状体植入术患者。测量远视、中视(70 cm)和近视(40 cm)的视敏度(VA)。此外,在1个月和6个月时获得离焦曲线,并在手术后3个月使用萨尔茨堡阅读桌®(SRD)进行阅读速度测试。分别于术后1、3、6个月进行VF-14问卷调查,测量眼镜的独立性,并于术后6个月进行满意度问卷调查。结果纳入48只眼。MID和PLUS术后未矫正的平均单眼VA分别为:距离(UDVA) 0.028±0.08 LogMAR和0.057±0.10,中间(uva) 0.035±0.10和0.037±0.09,近(UNVA) 0.078±0.11和0.030±0.10。双眼未校正的远视VA为- 0.022±0.02,中视为- 0.002,近视为0.015。术后6个月双眼离焦曲线在+0.50 D ~ - 2.50 D范围内均高于0 LogMAR, 6个月平均满意率为83%。结论Artis Symbiose®人工晶状体可提供远、中、近位置的功能性未矫正视力,无需额外的光学辅助。它是活动性老花眼患者的有效选择,具有连续和扩展的聚焦深度,与三焦植入物相比提供了额外的价值。ObjectifÉvaluer les r sultats cliniques aprires implant d 'une nouvelle lentile intraoculaire (LIO) correctrice de la presbytie: mod Artis Symbiose®(Cristalens Industrie,法国)。3 .法国布雷斯特第三阶段 )DesignÉtude前瞻性干预,非比较。其他患者有:宫颈内移植,宫颈内移植,宫颈内移植,宫颈内移植。L ' acuit visuelle (AV) en vision de loin, intermsamdiaire(70厘米)和de pr(40厘米)一个samursamae。另外,les courbes De d哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤哀伤。Le问卷VF-14安勤科技1,3等6月然后l 'intervention为了l 'independance面对des半月形等联合国de满意度问卷调查的疾病rempli当时de la看de suivi 6月。1 .“薪金薪金”包括48个月。L 'AV postopsamatraire non - corrigsamoire monoculaire moyenne, pour L 'implant MID和PLUS分别为0,028±0,08 LogMAR和0,057±0,10 de loin (UDVA), 0,035±0,10和0,037±0,09 en intermsamdiaire (uva), 0,078±0,11和0,030±0,10 de prods (UNVA)。En binoculaire, l 'AV non - corrigacemote - 0,022±0,02 de loin,−0,002 En intermsamdiaire,和0,015 de prodres。La courbe de散焦binoculaire 6月postoperatoire是au-dessus du LogMAR 0 + 0之间,50 D et−2、50 D是平均taux de满意度是83%。结论:le mod d 'implant Artis Symbiose®提供了一种视觉辅助功能,即:无矫正的内眦赘生物,远距离的内眦赘生物,无矫正的内眦赘生物,无矫正的内眦赘生物。将构成一个选项的有效性,以减少患者的预期活动,平均一个深度的时间,以持续的交换,交换的时间,交换的时间,交换的时间,交换的时间,交换的时间。
{"title":"Visual outcomes after implantation of a presbyopia-correcting IOL that combines extended depth-of-focus and progressive phase complementarity optics","authors":"J. Le Dinahet,&nbsp;A.-A. Benyoussef,&nbsp;B. Cochener-Lamard","doi":"10.1016/j.jfo.2025.104770","DOIUrl":"10.1016/j.jfo.2025.104770","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;To evaluate clinical outcomes after implantation of new presbyopia-correcting intraocular lens (IOL): Artis Symbiose® (Cristalens Industrie, France).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting&lt;/h3&gt;&lt;div&gt;Tertiary referral center, Brest, France.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;div&gt;Non-comparative prospective interventional study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Patients undergoing bilateral IOL implantation were included. Visual acuity (VA) for distance, intermediate (70&lt;!--&gt; &lt;!--&gt;cm) and near (40&lt;!--&gt; &lt;!--&gt;cm) vision were measured. In addition, defocus curves were obtained at 1 and 6&lt;!--&gt; &lt;!--&gt;months, and a reading speed test was assessed using the Salzburg Reading Desk® (SRD) 3&lt;!--&gt; &lt;!--&gt;months after surgery. The VF-14 questionnaire was evaluated at 1, 3 and 6&lt;!--&gt; &lt;!--&gt;months after surgery to measure spectacle independence, and a level of satisfaction questionnaire was completed at the 6-month follow-up visit.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The study included 48 eyes. Mean postoperative monocular uncorrected VA, for MID and PLUS respectively, was 0.028&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.08 LogMAR and 0.057&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.10 at distance (UDVA), 0.035&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.10 and 0.037&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.09 at intermediate (UIVA), 0.078&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.11 and 0.030&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.10 at near (UNVA). Binocularly, uncorrected VA was −0.022&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;0.02 at distance, −0.002 at intermediate, and 0.015 at near. The binocular defocus curve at 6&lt;!--&gt; &lt;!--&gt;months after surgery was above 0 LogMAR between +0.50 D and −2.50 D. The mean satisfaction rate at 6&lt;!--&gt; &lt;!--&gt;months was 83%.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;The Artis Symbiose® IOL provides functional uncorrected visual acuity at distance, intermediate and near positions, without the need for additional optical aid. It is an effective option in active presbyopic patients, with a continuous and extended depth-of-focus, providing added value compared to trifocal implants.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Évaluer les résultats cliniques après implantation d’une nouvelle lentille intraoculaire (LIO) correctrice de la presbytie : modèle Artis Symbiose® (Cristalens Industrie, France).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Lieu&lt;/h3&gt;&lt;div&gt;Centre de référence tertiaire, Brest, France.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;div&gt;Étude prospective interventionnelle non comparative.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Les patients bénéficiant d’une implantation bilatérale de LIO ont été inclus. L’acuité visuelle (AV) en vision de loin, intermédiaire (70&lt;!--&gt; &lt;!--&gt;cm) et de près (40&lt;!--&gt; &lt;!--&gt;cm) a été mesurée. De plus, les courbes de défocalisation ont été obtenues à 1 et 6 mois, et un test de vitesse de lecture a été évalué à l’aide du Salzburg Reading Desk® (SRD) 3 mois après l’intervention. Le questionnaire VF-14 a été évalué à 1, 3 et 6 mois après l’intervention pour mesurer l’indépendance vis-à-vis des lunettes et un questionnaire de satisfaction a été rempli lors d","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"49 3","pages":"Article 104770"},"PeriodicalIF":1.1,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146045200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Atypical presentation of AZOOR associated with optic disc edema]. [AZOOR伴视盘水肿的不典型表现]。
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-26 DOI: 10.1016/j.jfo.2026.104778
S Sadoun, M-B Rougier, M-N Delyfer, E Jomaa
{"title":"[Atypical presentation of AZOOR associated with optic disc edema].","authors":"S Sadoun, M-B Rougier, M-N Delyfer, E Jomaa","doi":"10.1016/j.jfo.2026.104778","DOIUrl":"https://doi.org/10.1016/j.jfo.2026.104778","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146063590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of Heterochromia iridum in a religious painting by Peter Paul Rubens (1577-1640). 彼得·保罗·鲁本斯(1577-1640)的一幅宗教画中的虹彩异色。
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-23 DOI: 10.1016/j.jfo.2026.104782
N Kluger
{"title":"A case of Heterochromia iridum in a religious painting by Peter Paul Rubens (1577-1640).","authors":"N Kluger","doi":"10.1016/j.jfo.2026.104782","DOIUrl":"https://doi.org/10.1016/j.jfo.2026.104782","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal imaging of congenital achromatopsia associated with dome-shaped macula. 先天性色盲伴穹状黄斑的多模态成像。
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.jfo.2026.104781
K El Matri, Y Houmane, A Bouatay, H Kamoun, L El Matri
{"title":"Multimodal imaging of congenital achromatopsia associated with dome-shaped macula.","authors":"K El Matri, Y Houmane, A Bouatay, H Kamoun, L El Matri","doi":"10.1016/j.jfo.2026.104781","DOIUrl":"https://doi.org/10.1016/j.jfo.2026.104781","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146040839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proliferative vitreoretinopathy-induced central retinal artery occlusion. 增生性玻璃体视网膜病变引起的视网膜中央动脉闭塞。
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-22 DOI: 10.1016/j.jfo.2026.104776
M Ghazaryan, L Sejournet, R Serra, V Labattut, T Mathis, L Kodjikian
{"title":"Proliferative vitreoretinopathy-induced central retinal artery occlusion.","authors":"M Ghazaryan, L Sejournet, R Serra, V Labattut, T Mathis, L Kodjikian","doi":"10.1016/j.jfo.2026.104776","DOIUrl":"https://doi.org/10.1016/j.jfo.2026.104776","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146040868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tuberculosis with mastoid and ocular involvement]. [伴有乳突和眼部受累的结核]。
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-21 DOI: 10.1016/j.jfo.2026.104779
E Boulert, J Bouleau
{"title":"[Tuberculosis with mastoid and ocular involvement].","authors":"E Boulert, J Bouleau","doi":"10.1016/j.jfo.2026.104779","DOIUrl":"https://doi.org/10.1016/j.jfo.2026.104779","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Granulome du corps ciliaire dans un contexte de panuvéite sarcoïdosique 结节性panuveite背景下的纤毛体肉芽肿
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-17 DOI: 10.1016/j.jfo.2025.104774
S. Brocquet-Lestrade , G. Morange , C. Schweitzer , M.B. Rougier
{"title":"Granulome du corps ciliaire dans un contexte de panuvéite sarcoïdosique","authors":"S. Brocquet-Lestrade ,&nbsp;G. Morange ,&nbsp;C. Schweitzer ,&nbsp;M.B. Rougier","doi":"10.1016/j.jfo.2025.104774","DOIUrl":"10.1016/j.jfo.2025.104774","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"49 2","pages":"Article 104774"},"PeriodicalIF":1.1,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145978057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspects épidémio-cliniques, angiographiques et thérapeutiques de la rétinopathie drépanocytaire au Burkina Faso 布基纳法索镰状细胞性视网膜病的流行病学、血管造影和治疗方面
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-16 DOI: 10.1016/j.jfo.2025.104772
D. Bengaly , W.P. Djiguimdé , M. Niampa , M. Yaméogo , Y.F. Lankoandé , J. Sanou , T.A. Meda , J.W. Diallo , A. Zabsonré
<div><h3>Introduction</h3><div>La drépanocytose est une maladie génétique autosomique récessive par mutation du gène de la <em>β</em> globine. La rétinopathie drépanocytaire est une complication fréquente de la drépanocytose.</div></div><div><h3>Patients et méthode</h3><div>Nous avons réalisé une étude multicentrique, transversale de type descriptif à collecte de données rétrospective et prospective entre janvier 2020 et janvier 2023 des patients pour rétinopathie drépanocytaire.</div></div><div><h3>Résultats</h3><div>Deux cent soixante-quatorze patients ont été vus, dont 148 hommes et 126 femmes, âgés de 9 à 80 ans avec une moyenne d’âge de 33,38 ans. Sur 274 patients examinés, 272 étaient porteurs de syndrome drépanocytaire majeur (261<!--> <!-->SC, 8<!--> <!-->SS et 3<!--> <!-->S/<em>β</em>-thalassémie). Les principales lésions observées au fond d’œil étaient les « Sea fan » (33,2 %), les anastomoses artériolo-veinulaires (28,4 %). À l’angiographie à la fluorescéine, le stade III de Goldberg prédominait, avec une fréquence de 37,2 % à l’œil droit et de 36,5 % à l’œil gauche. Sur 271 cas de rétinopathie drépanocytaire, la forme proliférante a été retrouvée chez 92,7 % des patients et la forme non proliférante représentait 6,3 %. Le traitement le plus réalisé était la photocoagulation au laser argon (44,5 %). Un cas d’injection d’anti-VEGF associé à la photocoagulation panrétinienne au laser argon a permis un gain visuel de 2 lignes.</div></div><div><h3>Conclusion</h3><div>La rétinopathie drépanocytaire proliférante représente une complication redoutable dans l’évolution de la drépanocytose. Le dépistage et le traitement précoce par photocoagulation au laser argon restent le pilier de la prévention des complications cécitantes. Les anti-VEGF ont un intérêt dans la prévention et dans le traitement des hémorragies intravitréennes.</div></div><div><h3>Introduction</h3><div>Sickle cell disease is an autosomal recessive genetic disorder caused by a mutation of the <em>β-globin</em> gene. Sickle cell retinopathy is a common complication of sickle cell disease.</div></div><div><h3>Patients and methods</h3><div>We conducted a multicenter, cross-sectional, descriptive study with both retrospective and prospective data collection between January 2020 and January 2023, including patients with sickle cell retinopathy.</div></div><div><h3>Results</h3><div>A total of 274 patients were examined, including 148 men and 126 women, aged 9 to 80 years, with a mean age of 33.38 years. Among the 274 patients, 272 had major sickle cell syndromes (261<!--> <!-->SC, 8<!--> <!-->SS, and 3<!--> <!-->S/<em>β</em>-thalassemia). The main fundus lesions observed were “sea fan” neovascularization (33.2%) and arteriovenous anastomoses (28.4%). On fluorescein angiography, Goldberg stage III predominated, with a frequency of 37.2% in the right eye and 36.5% in the left eye. Of the 271 cases of sickle cell retinopathy, the proliferative form was found in 92.7% of patients, while t
镰状细胞病是一种由β -蛋白基因突变引起的常染色体隐性遗传疾病。镰状细胞性视网膜病变是镰状细胞病的常见并发症。患者与方法我们在2020年1月至2023年1月期间对镰状细胞性视网膜病患者进行了一项多中心、横向、描述性、回顾性和前瞻性的研究。结果:274例患者,其中男性148例,女性126例,年龄在9岁至80岁之间,平均年龄为33.38岁。主要的眼底病变是“海扇”(33.2%)和动脉-静脉解剖(28.4%)。在荧光素血管造影中,Goldberg III期占主导地位,右眼为37.2%,左眼为36.5%。在271例镰状细胞性视网膜病变中,92.7%为增殖型,6.3%为非增殖型。最成功的治疗是氩激光光凝(44.5%)。抗vegf注射与泛视网膜光凝和氩激光相结合,获得了2行视觉增益。增殖性镰状细胞性视网膜病变是镰状细胞病发展的一种可怕的并发症。氩激光光凝的早期检测和治疗仍然是预防腭裂并发症的关键。抗vegf在静脉内出血的预防和治疗中具有重要意义。Sickle细胞病是一种由β-蛋白基因突变引起的常染色体隐性遗传疾病。这是一种常见的疾病,可能会导致严重的并发症。患者和方法我们在2020年1月至2023年1月期间进行了一项多中心、横断面、描述性研究,收集了回顾性和前瞻性数据,包括镰状细胞视网膜病变患者。共有274名患者接受了检查,其中包括148名男性和126名女性,年龄在9岁至80岁之间,平均年龄为33.38岁。在274例患者中,272例患有严重的镰状细胞综合征(261例SC、8例SS和3例S/β-地中海血症)。观察到的主要基底病变为“海鞘”新生血管化(33.2%)和动脉解剖(28.4%)。在荧光血管造影中,Goldberg III期占主导地位,右眼的频率为37.2%,左眼为36.5%。在271例镰状细胞视网膜病病例中,92.7%的患者发现了增殖型,而非增殖型占6.3%。最常进行的治疗是氩激光光凝(44.5%)。抗vegf注射一例与氩气激光全视网膜光凝相结合,获得两条线的视觉增益。增殖性镰状细胞视网膜病变是镰状细胞病过程中的一种严重并发症。氩激光光凝的早期检测和治疗仍然是预防视力威胁并发症的基石。抗vegf疗法在预防和管理玻璃出血方面是有用的。
{"title":"Aspects épidémio-cliniques, angiographiques et thérapeutiques de la rétinopathie drépanocytaire au Burkina Faso","authors":"D. Bengaly ,&nbsp;W.P. Djiguimdé ,&nbsp;M. Niampa ,&nbsp;M. Yaméogo ,&nbsp;Y.F. Lankoandé ,&nbsp;J. Sanou ,&nbsp;T.A. Meda ,&nbsp;J.W. Diallo ,&nbsp;A. Zabsonré","doi":"10.1016/j.jfo.2025.104772","DOIUrl":"10.1016/j.jfo.2025.104772","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;La drépanocytose est une maladie génétique autosomique récessive par mutation du gène de la &lt;em&gt;β&lt;/em&gt; globine. La rétinopathie drépanocytaire est une complication fréquente de la drépanocytose.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Patients et méthode&lt;/h3&gt;&lt;div&gt;Nous avons réalisé une étude multicentrique, transversale de type descriptif à collecte de données rétrospective et prospective entre janvier 2020 et janvier 2023 des patients pour rétinopathie drépanocytaire.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;div&gt;Deux cent soixante-quatorze patients ont été vus, dont 148 hommes et 126 femmes, âgés de 9 à 80 ans avec une moyenne d’âge de 33,38 ans. Sur 274 patients examinés, 272 étaient porteurs de syndrome drépanocytaire majeur (261&lt;!--&gt; &lt;!--&gt;SC, 8&lt;!--&gt; &lt;!--&gt;SS et 3&lt;!--&gt; &lt;!--&gt;S/&lt;em&gt;β&lt;/em&gt;-thalassémie). Les principales lésions observées au fond d’œil étaient les « Sea fan » (33,2 %), les anastomoses artériolo-veinulaires (28,4 %). À l’angiographie à la fluorescéine, le stade III de Goldberg prédominait, avec une fréquence de 37,2 % à l’œil droit et de 36,5 % à l’œil gauche. Sur 271 cas de rétinopathie drépanocytaire, la forme proliférante a été retrouvée chez 92,7 % des patients et la forme non proliférante représentait 6,3 %. Le traitement le plus réalisé était la photocoagulation au laser argon (44,5 %). Un cas d’injection d’anti-VEGF associé à la photocoagulation panrétinienne au laser argon a permis un gain visuel de 2 lignes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;La rétinopathie drépanocytaire proliférante représente une complication redoutable dans l’évolution de la drépanocytose. Le dépistage et le traitement précoce par photocoagulation au laser argon restent le pilier de la prévention des complications cécitantes. Les anti-VEGF ont un intérêt dans la prévention et dans le traitement des hémorragies intravitréennes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;Sickle cell disease is an autosomal recessive genetic disorder caused by a mutation of the &lt;em&gt;β-globin&lt;/em&gt; gene. Sickle cell retinopathy is a common complication of sickle cell disease.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Patients and methods&lt;/h3&gt;&lt;div&gt;We conducted a multicenter, cross-sectional, descriptive study with both retrospective and prospective data collection between January 2020 and January 2023, including patients with sickle cell retinopathy.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 274 patients were examined, including 148 men and 126 women, aged 9 to 80 years, with a mean age of 33.38 years. Among the 274 patients, 272 had major sickle cell syndromes (261&lt;!--&gt; &lt;!--&gt;SC, 8&lt;!--&gt; &lt;!--&gt;SS, and 3&lt;!--&gt; &lt;!--&gt;S/&lt;em&gt;β&lt;/em&gt;-thalassemia). The main fundus lesions observed were “sea fan” neovascularization (33.2%) and arteriovenous anastomoses (28.4%). On fluorescein angiography, Goldberg stage III predominated, with a frequency of 37.2% in the right eye and 36.5% in the left eye. Of the 271 cases of sickle cell retinopathy, the proliferative form was found in 92.7% of patients, while t","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"49 2","pages":"Article 104772"},"PeriodicalIF":1.1,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145978054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iridocorneal angle changes after implantable collamer lens (ICL) implantation: A 10-year follow-up study 人工晶状体(ICL)植入术后虹膜角膜角度的改变:一项10年随访研究
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-16 DOI: 10.1016/j.jfo.2025.104773
A. Macarro-Merino , J.I. Fernández-Vigo , I. Almorín-Fernández-Vigo , B. Kudsieh , L. de-Pablo-Gómez-de-Liaño , C. Fernández-Vigo , J.Á. Fernández-Vigo
<div><h3>Purpose</h3><div>To evaluate changes over a 10-year period in the iridocorneal angle following implantable collamer lens (ICL) implantation.</div></div><div><h3>Methods</h3><div>This retrospective study included 48 eyes of 24 patients who underwent ICL implantation. Trabecular-iris angle (TIA<sub>500</sub>), trabecular-iris space area (TISA<sub>500</sub>), and angle opening distance (AOD<sub>500</sub>) at 500<!--> <!-->μm from the scleral spur, along with vault distance, were measured using Fourier-domain anterior segment optical coherence tomography (AS-OCT). Primary endpoints were changes in TIA<sub>500</sub>, TISA<sub>500</sub>, and AOD<sub>500</sub> from baseline to year 10. Secondary outcomes included changes in vault and predictors of anterior chamber angle opening.</div></div><div><h3>Results</h3><div>Forty-eight eyes of 24 patients were included in the study. The mean spherical equivalent was −9.1<!--> <!-->±<!--> <!-->3.9 diopters, with 60.4% of eyes receiving a spherical ICL and 39.6% a toric ICL. Significant reductions in nasal and temporal TIA<sub>500</sub> (<em>P</em> <!--><<!--> <!-->0.001) were observed at month 1, stabilizing over 10 years. Similar patterns were found for TISA<sub>500</sub> and AOD<sub>500</sub>. The vault demonstrated a gradual decrease over time. Multiple regression analysis revealed that preoperative TIA<sub>500</sub> and postoperative vault at 1 month were significantly associated with TIA<sub>500</sub> at both 1 month (<em>P</em> <!--><<!--> <!-->0.0001, <em>P</em> <!-->=<!--> <!-->0.0050, <em>P</em> <!-->=<!--> <!-->0.0080, and <em>P</em> <!-->=<!--> <!-->0.0191, respectively) and 10 years postoperatively (<em>P</em> <!-->=<!--> <!-->0.0011, <em>P</em> <!-->=<!--> <!-->0.0016, <em>P</em> <!-->=<!--> <!-->0.0128, and <em>P</em> <!-->=<!--> <!-->0.0293, respectively) in the nasal and temporal quadrants.</div></div><div><h3>Conclusion</h3><div>ICL implantation provides long-term stability in the iridocorneal angle opening, with preoperative angle measurements serving as key predictors of long-term outcomes. This stability was maintained even after a decade, highlighting the procedure's durability in terms of anterior segment configuration.</div></div><div><h3>Objectif</h3><div>Évaluer l’évolution de l’angle iridocornéen après implantation de lentilles phakes en collamère (ICL) sur une période de dix ans.</div></div><div><h3>Méthodes</h3><div>Cette étude rétrospective a inclus 48 yeux de 24 patients ayant fait l’objet d’une implantation d’ICL. L’angle trabéculo-irien (TIA<sub>500</sub>), la surface de l’espace trabéculo-irien (TISA<sub>500</sub>) et la distance d’ouverture angulaire (AOD<sub>500</sub>) à 500<!--> <!-->μm de l’épine sclérale, ainsi que le vault, ont été mesurés à l’aide de la tomographie par cohérence optique du segment antérieur en domaine de Fourier (AS-OCT). Les critères principaux étaient les variations de TIA<sub>500</sub>, TISA<sub>500</sub> et AOD<sub>500</sub> entre l’évalu
目的评价人工晶状体(ICL)植入术后虹膜角膜角10年间的变化。方法对24例人工晶体植入术患者48眼进行回顾性研究。采用傅里叶域前段光学相干断层扫描(AS-OCT)测量距巩膜骨刺500 μm处的小梁-虹膜角(TIA500)、小梁-虹膜间隙面积(TISA500)和角开口距离(AOD500)以及穹窿距离。主要终点是TIA500、TISA500和AOD500从基线到第10年的变化。次要结局包括拱顶的变化和前房角开度的预测因子。结果24例患者48只眼纳入研究。平均球面等效度为- 9.1±3.9屈光度,60.4%的眼睛接受球形ICL, 39.6%的眼睛接受圆环ICL。在第1个月观察到鼻部和颞部TIA500显著下降(P < 0.001),并在10年内稳定下来。TISA500和AOD500也发现了类似的模式。随着时间的推移,拱顶逐渐减少。多元回归分析显示,术前和术后1个月的TIA500与术后1个月(P = 0.0001, P = 0.0050, P = 0.0080, P = 0.0191)和术后10年(P = 0.0011, P = 0.0016, P = 0.0128, P = 0.0293)的鼻、颞象限TIA500均显著相关。结论icl植入术可保证虹膜角膜角开度的长期稳定性,术前角度测量是预测长期疗效的关键指标。这种稳定性甚至在十年后仍然保持,突出了手术在前节段结构方面的耐久性。ObjectifÉvaluer本研究对24例患者进行了回顾性分析,其中24例患者的ICL植入术失败。L ' angle trabcullo - ien (TIA500), L ‘ surface de L ’空间trabcullo - ien (TISA500)和la distance d ' ouverde angulaire (AOD500), 500 μm de L ' castine, ainsi que le vault, ont samtastursamos - castol ' de tomography par cococonconastacoptique du segment antsamrieur en domain de Fourier (AS-OCT)。3 .《关于 ()和()的变化》,《关于 )》。第二阶段的标准是综合的,例如,所有的因素都是可变的,例如,所有的因素都是可变的。对24例患者进行了统计分析。1’s samsamrique与1’s samsamrique等同,1’s samsamrique与1’s samrique等同,3’s samrique与1’s samrique等同,3’s samrique与1’s samrique等同,平均64.4%。(p < 001)和(p < 001)、(s < 001)、(s < 001)、(s < 001)、(s < 001)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)、(s)。我们的目标是一个渐进渐进的目标。利用TIA500与TIA500的测量数据(p = 0,0001; p = 0,0050; p = 0,0080; p = 0,0191)和cedans (p = 0,0011; p = 0,0016; p = 0,0128; p = 0,0293)与鼻部和颞部的象限进行比较,分析了与TIA500的测量数据(p = 0,0011; p = 0,0016; p = 0,0128; p = 0,0293)相关联的变差回归系数。结论icl植入术保证了一种稳定、持久的虹膜夹闭术。这些措施主要针对的是,从长期来看,这些措施主要针对的是:保持稳定,维持部分和部分之间的过渡,维持部分和部分之间的过渡,维持部分和部分之间的过渡。
{"title":"Iridocorneal angle changes after implantable collamer lens (ICL) implantation: A 10-year follow-up study","authors":"A. Macarro-Merino ,&nbsp;J.I. Fernández-Vigo ,&nbsp;I. Almorín-Fernández-Vigo ,&nbsp;B. Kudsieh ,&nbsp;L. de-Pablo-Gómez-de-Liaño ,&nbsp;C. Fernández-Vigo ,&nbsp;J.Á. Fernández-Vigo","doi":"10.1016/j.jfo.2025.104773","DOIUrl":"10.1016/j.jfo.2025.104773","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;To evaluate changes over a 10-year period in the iridocorneal angle following implantable collamer lens (ICL) implantation.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This retrospective study included 48 eyes of 24 patients who underwent ICL implantation. Trabecular-iris angle (TIA&lt;sub&gt;500&lt;/sub&gt;), trabecular-iris space area (TISA&lt;sub&gt;500&lt;/sub&gt;), and angle opening distance (AOD&lt;sub&gt;500&lt;/sub&gt;) at 500&lt;!--&gt; &lt;!--&gt;μm from the scleral spur, along with vault distance, were measured using Fourier-domain anterior segment optical coherence tomography (AS-OCT). Primary endpoints were changes in TIA&lt;sub&gt;500&lt;/sub&gt;, TISA&lt;sub&gt;500&lt;/sub&gt;, and AOD&lt;sub&gt;500&lt;/sub&gt; from baseline to year 10. Secondary outcomes included changes in vault and predictors of anterior chamber angle opening.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Forty-eight eyes of 24 patients were included in the study. The mean spherical equivalent was −9.1&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;3.9 diopters, with 60.4% of eyes receiving a spherical ICL and 39.6% a toric ICL. Significant reductions in nasal and temporal TIA&lt;sub&gt;500&lt;/sub&gt; (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.001) were observed at month 1, stabilizing over 10 years. Similar patterns were found for TISA&lt;sub&gt;500&lt;/sub&gt; and AOD&lt;sub&gt;500&lt;/sub&gt;. The vault demonstrated a gradual decrease over time. Multiple regression analysis revealed that preoperative TIA&lt;sub&gt;500&lt;/sub&gt; and postoperative vault at 1 month were significantly associated with TIA&lt;sub&gt;500&lt;/sub&gt; at both 1 month (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.0001, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0050, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0080, and &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0191, respectively) and 10 years postoperatively (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0011, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0016, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0128, and &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.0293, respectively) in the nasal and temporal quadrants.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;ICL implantation provides long-term stability in the iridocorneal angle opening, with preoperative angle measurements serving as key predictors of long-term outcomes. This stability was maintained even after a decade, highlighting the procedure's durability in terms of anterior segment configuration.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Évaluer l’évolution de l’angle iridocornéen après implantation de lentilles phakes en collamère (ICL) sur une période de dix ans.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Cette étude rétrospective a inclus 48 yeux de 24 patients ayant fait l’objet d’une implantation d’ICL. L’angle trabéculo-irien (TIA&lt;sub&gt;500&lt;/sub&gt;), la surface de l’espace trabéculo-irien (TISA&lt;sub&gt;500&lt;/sub&gt;) et la distance d’ouverture angulaire (AOD&lt;sub&gt;500&lt;/sub&gt;) à 500&lt;!--&gt; &lt;!--&gt;μm de l’épine sclérale, ainsi que le vault, ont été mesurés à l’aide de la tomographie par cohérence optique du segment antérieur en domaine de Fourier (AS-OCT). Les critères principaux étaient les variations de TIA&lt;sub&gt;500&lt;/sub&gt;, TISA&lt;sub&gt;500&lt;/sub&gt; et AOD&lt;sub&gt;500&lt;/sub&gt; entre l’évalu","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"49 2","pages":"Article 104773"},"PeriodicalIF":1.1,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145978053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Panuveitis with occlusive vasculitis following intravitreal injection of faricimab. 玻璃体内注射法昔单抗后的全葡萄膜炎伴闭塞性血管炎。
IF 1.1 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2026-01-13 DOI: 10.1016/j.jfo.2025.104761
S Ouattara, C Chen, M Selhane, V Pipelart
{"title":"Panuveitis with occlusive vasculitis following intravitreal injection of faricimab.","authors":"S Ouattara, C Chen, M Selhane, V Pipelart","doi":"10.1016/j.jfo.2025.104761","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104761","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal Francais D Ophtalmologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1